CME

Adult ADHD: A Diagnostics Challenge and Treatment Dilemma: June 2017

Adult ADHD: A Diagnostics Challenge and Treatment Dilemma: June 2017

Keck School of Medicine of USC and Psychiatric Annals

Instructions

Table of Contents

Attention-Deficit/Hyperactivity Disorder in Adults: Changes in Diagnostic Criteria in DSM-5

Ali M. Hashmi, MD; Nazish Imran, MBBS, MRCPsych; Ali Ahsan Ali, MD; and Asim A. Shah, MD

The Role of Psychologists in Adult Attention-Deficit/Hyperactivity Disorder Testing

John F. Linck, PhD, ABPP-CN; Britta Ostermeyer, MD, MBA, FAPA; Nizete-Ly Valles, PhD; Araceli Flores, PhD; and Asim A. Shah, MD

To Prescribe or Not? Pharmacological Options in Adult Attention-Deficit/Hyperactivity Disorder

Aya Aoshima-Kilroy, MD; Sophia Banu, MD; Sade Udoetuk, MD; Asim A. Shah, MD; and Nidal Moukaddam, MD, PhD

Adult Attention-Deficit/Hyperactivity Disorder: Diagnostic Dilemma with Case Examples

Asim A. Shah, MD; Lindsay N. French-Rosas, MD; Kim-Lan T. Czelusta, MD; Sophia Banu, MD; and Jin Y. Han, MD

Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?

Swapna Deshpande, MD; Britta Ostermeyer, MD, MBA, FAPA; Akshay Lokhande, MD, MHA; Humaira Abid, MD; and Asim A. Shah, MD

Sponsorship Statement: This CME activity is jointly sponsored by Keck School of Medicine of USC and Psychiatric Annals.

Support Statement: There is no commercial support for this activity.

Learning Objectives:

1. Recognize the diagnosis of adult attention-deficit/hyperactivity disorder.

2. Discuss the psychologist’s role in psychological or neuropsychological testing in patients undergoing evaluation for adult attention-deficit/hyperactivity disorder.

3. Identify pharmacological options that can be used to treat adult attention-deficit/hyperactivity disorder.

4. Recognize the comorbidities associated with adult attention-deficit/hyperactivity disorder.

5. Identify treatment protocols for patients with adult attention-deficit/hyperactivity disorder.

Faculty names and affiliations:  See authors above

Guest Editor: Asim A. Shah, MD

Reviewer names:  Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals

Disclosure statement:  In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:   Jan Fawcett, MD, has no relevant financial relationships to disclose. Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.

Authors report the following financial relationships: Ali M. Hashmi has no relevant financial relationships to disclose. Nazish Imran has no relevant financial relationships to disclose. Ali Ahsan Ali has no relevant financial relationships to disclose. Asim A. Shah has no relevant financial relationships to disclose. John F. Linck has no relevant financial relationships to disclose. Britta Ostermeyer has no relevant financial relationships to disclose. Nizete-Ly Valles has no relevant financial relationships to disclose. Araceli Flores has no relevant financial relationships to disclose. Aya Aoshima-Kilroy has no relevant financial relationships to disclose. Sophia Banu has no relevant financial relationships to disclose. Sade Udoetuk has no relevant financial relationships to disclose. Nidal Moukaddam has no relevant financial relationships to disclose. Lindsay N. French-Rosas has no relevant financial relationships to disclose. Kim-Lan T. Czelusta has no relevant financial relationships to disclose. Jin Y. Han has no relevant financial relationships to disclose. Swapna Deshpande has no relevant financial relationships to disclose. Akshay Lokhande has no relevant financial relationships to disclose. Humaira Abid has no relevant financial relationships to disclose. Signed disclosures are on file at Keck School of Medicine of USC.

Accreditation statement(s):  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Keck School of Medicine of USC and SLACK Incorporated. The Keck School of Medicine of USC is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation: The Keck School of Medicine of USC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  June 1, 2017. Expiration Date:  July 1, 2020.

How to participate:  To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Keck School of Medicine of USC will issue an AMA PRA Category 1 Credit(s)™ certificate.

Target audience:  This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.

Unlabeled and investigational usage statement:  The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Copyright statement:  Copyright © 2017 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.

Instructions

page 1 of 9